BSHC
TMO icon

Breed's Hill Capital’s Thermo Fisher Scientific TMO Stock Holding History

Breed's Hill Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$320K Sell
788
-30
-4% -$12.5K 0.15% 90
2025
Q1 		$407K Buy
818
+118
+17% +$63.9K 0.22% 77
2024
Q4 		$364K Buy
+700
New +$385K 0.19% 82

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Breed's Hill Capital's TMO Position: Q2 2025 in Review

Breed's Hill Capital reduced its Thermo Fisher Scientific (TMO) stake by 3.7% in Q2 2025, selling an estimated $12.5K and leaving 788 shares worth $320K. The position accounts for 0.15% of the portfolio, ranked #90.

Breed's Hill Capital first reported a position in TMO in Q4 2024 and has held it in 3 quarters since. The position peaked at $407K in Q1 2025. 2,458 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Breed's Hill Capital held 788 shares of Thermo Fisher Scientific worth $320K as of Q2 2025.
  • Breed's Hill Capital sold 30 Thermo Fisher Scientific shares in Q2 2025, an estimated $12.5K.
  • Thermo Fisher Scientific made up 0.15% of Breed's Hill Capital's portfolio in Q2 2025, its #90 holding.
  • Breed's Hill Capital first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 3 quarters since.
  • Breed's Hill Capital's Thermo Fisher Scientific position peaked at $407K in Q1 2025.
  • 2,458 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.